The health care industry has seen a significant increase in lobbying efforts. This surge in lobbying is reportedly linked to various factors, including a recent government program launch and an executive order on competition. The pharmaceutical industry is also on pace for record lobbying spending, although the overall scope and impact of the lobbying efforts are not entirely clear.